ARCHIVES

FDA Approves NDA for Sodium Fluoride F18

This article is from The Cancer Letter archive.

Vol. 37 No. 05 | February 4, 2011

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Health Professional Training Needs Improvement, IOM Says.

July 4, 2003

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010